<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Topics tagged with sermorelin]]></title><description><![CDATA[A list of topics that have been tagged with sermorelin]]></description><link>https://community.peptidecritic.com/tags/sermorelin</link><generator>RSS for Node</generator><lastBuildDate>Sat, 04 Apr 2026 10:01:59 GMT</lastBuildDate><atom:link href="https://community.peptidecritic.com/tags/sermorelin.rss" rel="self" type="application/rss+xml"/><pubDate>Invalid Date</pubDate><ttl>60</ttl><item><title><![CDATA[Sermorelin Research Dosing Protocol]]></title><description><![CDATA[I know sermorelin is FDA approved and very safe. I researched it for a few months when I started this adventure. I have to say results are subtle at best. As compared with CJC/Ipamorelin, which is more like a shotgun. FWIW, my sermorelin research was in line with the prescriber’s recommendation, while CJC/Ipamorelin was inline with common protocols(200-300mcg/day).
I don’t completely dismiss it the way a lot of YouTubers do, but for researchers who can tolerate it and are less patient, it seems most of the other GHRH peptides give more noticeable results faster.
]]></description><link>https://community.peptidecritic.com/topic/341/sermorelin-research-dosing-protocol</link><guid isPermaLink="true">https://community.peptidecritic.com/topic/341/sermorelin-research-dosing-protocol</guid><dc:creator><![CDATA[ResearchCat]]></dc:creator><pubDate>Invalid Date</pubDate></item></channel></rss>